Objectives: With the world population rapidly aging, it is increasingly important to identify sociodemographic, cognitive, and clinical features that predict poor outcome in geriatric depression. Self-report measures of resilience-ie, the ability to adapt and thrive in the face of adversity-may identify those depressed older adults with more favorable prognoses. Conclusions: Self-reported resilience may predict greater responsivity to antidepressant medication in older adults with MDD. Future research should investigate the potential for resilience training-and in particular, interventions designed to increase accommodative coping-to promote sustained remission of geriatric depression.
| INTRODUCTION
Geriatric depression is a common and debilitating disorder, with roughly 9% of geriatric primary care patients meeting criteria for MDD. 1 Geriatric depression has a poorer prognosis compared to depression experienced earlier in life, with lower rates of remission and higher rates of recurrence following first-line antidepressant treatment. [2] [3] [4] [5] [6] [7] [8] With the world population rapidly aging, it is increasingly important to identify sociodemographic, cognitive, and clinical features that predict poor outcome in geriatric depression to facilitate more targeted and effective interventions.
Studies investigating the relation between demographic variables
and remission in geriatric samples have reported inconsistent findings.
For example, a study of 215 depressed adults over the age of 60 found no effect of any demographic variable (age, gender, race, or education) on remission occurrence. 9 By contrast, other studies of the same age group have found that African American participants are less likely to respond with escitalopram treatment 10 and males are less likely to remit with venlafaxine. 11 However, a patient-level meta-analysis of 7 placebo-controlled trials of second-generation antidepressants for geriatric depression found that sex did not moderate treatment response. 5 Research investigating age of depression onset as a predictor of treatment response has also reported contradictory results. 12 For example, several studies have found that early onset depression is associated with poorer treatment response, 13 slower remission, 14 and higher rates of recurrence 15, 16 compared to late-onset depression.
By contrast, other studies have found that late-onset depression predicts poorer response to treatment 17 and more frequent and earlier relapse, 18 while yet other research has reported no effect. 19 One possible explanation is that greater number of previous episodes (rather than earlier onset per say) predicts poorer treatment response. Partial evidence for this hypothesis comes from a study of 210 depressed adults ages 69 and older, which found that among those with lateonset depression, recurrent depression predicted delayed response to pharmacotherapy compared to single-episode depression. 20 Additionally, those with recurrent depression were more likely to require pharmacotherapy augmentation, regardless of age of onset. Reynolds and colleagues propose that late onset be considered a proxy for other variables (neuropsychological impairment, structural brain abnormalities, less family history of mood disorders, and fewer previous episodes) that can affect treatment response. 14 Multiple studies have found that executive dysfunction predicts poor and slow response to antidepressants in geriatric depression. [21] [22] [23] [24] [25] [26] In particular, cognitive interference and impaired semantic organization have repeatedly been linked to poor rates of remission. 27 Other research has focused on clinical and social factors that predict treatment response in geriatric samples. Hopelessness, 10 33 which a systematic review identified as having the best psychometric properties out of the 17 resilience scales identified. 34 Exploratory factor analysis of data collected from 337 older adults with MDD yielded 4 factors: (1) "grit," reflecting perseverance and passion for long-term goals; (2) "active coping self-efficacy," reflecting self-efficacy for coping with stress via problem-focused strategies; (3)
"accommodative coping self-efficacy," reflecting self-efficacy for adapting to sources of stress; and (4) "spirituality," reflecting endorsement of spiritual beliefs. 32 Each factor was significantly associated with lower severity of depressive symptoms and apathy. 32 Other studies have similarly found that spirituality, 35, 36 greater meaning/purpose, [37] [38] [39] greater coping self-efficacy, 40 and self-reported use of active 41 and accommodative coping strategies 42 are associated with lower severity of geriatric depression. Because accommodative coping is thought to increase over the life span, 43, 44 
Key points
• Greater baseline resilience predicted treatment response and remission in depressed older adults receiving antidepressant treatment.
• The resilience factor accommodative coping selfefficacy uniquely predicted treatment response and remission.
• Future research should evaluate the potential for resilience training-and in particular, interventions designed to increase accommodative coping-to promote sustained remission of geriatric depression.
a strong sense of purpose"), (2) active coping self-efficacy (eg, "I am in control of my life"), (3) accommodative coping self-efficacy (eg, "I am able to adapt to change"), and (4) spirituality (eg, "I believe things happen for a reason"). A reliability analysis (with each item included only in the factor on which it loaded most strongly) using data from the larger EFA sample (N = 337) yielded the following Cronbach α estimates: total CD-RISC: 0.92, factor 1: 0.89, factor 2: 0.91, factor 3:
0.90, factor 4: 0.71.
| Depression and apathy
Severity of depressive symptoms was assessed with the self-report Geriatric Depression Scale (GDS) 49, 50 and the 24-item clinician-rated HAM-D. 47, [51] [52] [53] Apathy was evaluated using the clinician-rated Apathy Evaluation Scale (AES). 54 AES total scores range from 18 to 72 with lower scores indicating greater apathy.
| Physical health
Medical comorbidity was quantified using the clinician-rated Cumula- 
| Analyses
Prior to analyses, data were inspected for outliers, skewness, and First, a series of logistic regression models were estimated with remission as the dependent variable and each of the above predictive variables as the independent variable. Because the aim of these preliminary analyses was to select relevant variables for further multivariable analyses, all variables found to be significant at a level of P < 0.1 were retained. We also used the stepwise selection method, with an inclusion cutoff of α = .05, to identify possible predictors because some variables may affect the outcome differently when they are in a model simultaneously. We then estimated a multivariable logistic regression model including the aforementioned predictor variables.
This was followed by pruning nonsignificant predictors and comparing model fit by using the Akaike information criterion, which estimates the relative quality of statistical models for a given data set. An a priori decision was made that if total resilience was obtained as a predictor, exploratory analyses would be conducted to determine whether any of the 4 resilience factors were also predictive of remission. The same procedure was used to determine which of the demographic, cognitive, clinical, and psychosocial variables significantly predicted our secondary outcome, treatment response. Finally, we examined whether the treatment group to which the participant was randomized significantly moderated any of the observed associations.* Significance was set at P < 0.05 for all inferences.
3 | RESULTS
| Sample characteristics
Characteristics of the sample at baseline are summarized in Table 1 .
The average age of participants was 70 (range = 60-89 years). 
| Modeling of remission
Univariate analyses using remission as the outcome (Table 2) 
| Moderation by treatment group
Treatment group did not significantly moderate the effect of baseline resilience on either remission (interaction term of treatment group × resilience
Wald χ 2 = 0.4, P = 0.5) or treatment response (Wald χ 2 = 0.9, P = 0.4).
| DISCUSSION
The current study evaluated the utility of baseline demographic, cognitive, clinical, and psychosocial factors in predicting responsivity to antidepressant treatment in a sample of 143 older adults with MDD.
We found that participants with greater self-reported baseline resilience were more likely to experience improvement or remission from depression with antidepressant treatment. This finding is consistent with conceptualizations of resilience as "the ability to adapt to and recover from stress," 58 and supports the predictive validity of the CD-RISC in geriatric depression. Treatment group did not moderate the effect of resilience on treatment response or remission, suggesting that individuals with higher baseline resilience were more likely to improve regardless of the antidepressant medication(s) to which they were randomized.
Although no other studies to our knowledge have investigated self-reported resilience as a predictor of remission in individuals with MDD, our findings are highly similar to the results of a study of 92 adults receiving pharmacotherapy for posttraumatic stress disorder (PTSD) (60% of whom also met criteria for MDD). 59 In that study, baseline self-reported resilience significantly predicted treatment response. Specifically, a 1-unit (ie, 1%) increase in baseline CD-RISC score was associated with a 4% increase in the odds of PTSD improvement and a 3% to 4% increase in the odds of PTSD remission. In our study, a 1-unit increase in baseline resilience was associated with a For continuous variables, odds ratios were calculated with regard to a 1-unit increase in the total measure score. "Onset" refers to onset of major depressive disorder.
OR, odds ratio; CI, confidence interval; MMSE, Mini-Mental State Exam; GDS, Geriatric Depression Scale; HAM-D, Hamilton Depression Rating Scale; HAM-A, Hamilton Anxiety Rating Scale; AES, Apathy Evaluation Scale; CD-RISC, Connor-Davidson Resilience Scale; CIRS, Cumulative Illness Rating Scale for Geriatrics.
3% increase in the odds of MDD improvement and a 3.5% increase in the odds of MDD remission. Furthermore, the authors found that a 1-unit (25% increase) on an item indicating use of cognitive restructuring (ie, "I try to see the humorous side of things when I am faced with problems") was associated with a 125% increase in the odds of PTSD improvement. As this item loaded most strongly on the accommodative coping self-efficacy factor in our recent EFA, 32 this is consistent with our finding that accommodative coping self-efficacy was uniquely predictive of treatment response in our sample.
Consistent with previous studies of antidepressant treatment of geriatric depression, we found no relation between sex 5 or education 9,10 and posttreatment depressive symptoms in our sample.
Consistent with 1 previous study, 9 but in contrast to another, 10 we found no association of race with treatment outcome.
In contrast to previous research, 27 we found no effect of executive functioning on treatment response or remission in our sample. Because we screened out individuals with an MMSE score <26, it is possible that our sample contained insufficient variability in neurocognitive performance to detect an effect. Although univariate analyses identified lower baseline severity of depressive symptoms and apathy as predictors of remission and response (respectively) at the P < 0.10 level, these associations were not significant in the multivariable logistic regression which included baseline resilience.
Larger and more inclusive studies with cognitive cohorts are needed to replicate these findings.
Of the 4 previously identified resilience factors, accommodative coping self-efficacy uniquely predicted treatment response and remission. While active (problem-focused) attempts to "solve" a source of stress are adaptive when facing a controllable stressor, the ability to accommodate is associated with better mental health outcomes in the face of uncontrollable stress. 42, [60] [61] [62] [63] [64] Older adults may encounter uncontrollable stress more frequently than younger adults (eg, sleep changes, chronic pain, declining cognitive abilities), 65 which could make accommodative coping especially essential in geriatric populations. 66 Consistent with this notion, older adults appear to engage in more accommodative coping 43 and less instrumental action coping 66 compared to younger adults. One explanation for why resilience predicts treatment response in geriatric depression lies in a possibly shared neurobiological etiology. We recently determined that the resilience factor "grit"
was associated with fractional anisotropy (FA) in the cingulum fibers and the callosal region connecting prefrontal cortex of depressed older adults. 69 Similarly, resilience in adolescence has been associated with higher FA in an anterior cingulate region projecting to frontal areas subserving cognitive processes. 70 Correspondingly, several studies have identified neural differences between those who achieve remission with treatment and those who fail to remit. For example, a study of 62 depressed older adults found that those who remitted with escitalopram had greater FA in the rostral and dorsal anterior cingulate cortex (ACC), the dorsolateral prefrontal cortex (DLPFC), the genu of the corpus callosum, white matter adjacent to the hippocampus, multiple posterior cingulate cortex regions, and insular white matter relative to those who failed to remit. 71 Another study found greater resting functional connectivity in the bilateral dorsal ACC, right DLPFC, and bilateral inferior parietal cortices in older adult remitters compared to nonremitters following escitalopram treatment. 72 Microstructural abnormalities in the corpus callosum, left superior corona radiate, and right inferior longitudinal fasciculum have also been associated with lower rates of remission in geriatric depression. 73 Additional research is needed to further investigate psychosocial, cognitive, and neural indicators of resilience (including greater capacity for treatment response) as well as to identify the most effective therapies for depressed older adults with differing resilience "signatures."
Several limitations of the current study should be noted. First, as our study did not include a placebo-only or no-treatment control condition, the degree to which resilience predicts remission from geriatric depression in the absence of antidepressant treatment is unknown. The greater subsequent improvement observed in those with greater baseline resilience may be because of the combination of resilience and antidepressant medication, resilience and nonspecific factors, or resilience alone. Presumably, resilience also predicts remission from geriatric depression in the absence of treatment 58, 74 ; future placebo-controlled trials are needed to determine whether this effect is stronger or weaker among those receiving antidepressant treatment.
Second, resilience was assessed via self-report and as such is susceptible to issues of impression management, introspective ability, and degree of understanding. Possible future directions include the use of neural, physiological, and behavioral (ie, laboratory or field) measures of resilience to corroborate these findings. Such methods have been validated in individuals without psychopathology, 58 and researchers have begun investigating the neural signature of resilience in individuals in remission from MDD. 75 However, few studies have attempted to identify the predictive validity of such an index (eg, a laboratory attention task) in individuals currently experiencing a depressive episode. 76 Future research in this area would be useful.
A third limitation is that our sample was relatively homogenous with regard to demographic features such as age, race, and education.
Recruitment of more racially and socioeconomically diverse samples will allow for tests of group differences in the value of resilience for predicting treatment response. Additionally, because our recruitment criteria excluded participants with significant psychiatric comorbidity, whether our results generalize to depressed older adults with cooccurring cognitive impairment or psychiatric conditions (eg, substance use disorder, PTSD) is unknown. 58, 77 is that resilience is a dynamic capacity that is influenced by both internal and environmental resources. 78 As such, we believe our findings point to the potential utility of resilience training in geriatric depression. In particular, those patients with low accommodative coping self-efficacy may benefit from psychotherapies that include components designed to increase acceptance (eg, PST). The potential for such therapies to facilitate sustained remission with and without pharmacological treatment is an important area for future research that will help optimize treatment of geriatric depression.
